Limitrin (DICAM): a new prognostic biomarker and therapeutic target for breast cancer brain metastasis
Conference Paper
-
- Overview
-
- Additional Document Info
-
- View All
-
Overview
publication date
has subject area
published in
Additional Document Info
Publisher
start page
end page
volume
issue